$AEO
AMERICAN EAGLE OUTFITTERS INC

2020 Q3 Form 10-Q Financial Statement

#000156459020042969 Filed on September 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $883.5M $1.041B $886.3M
YoY Change -15.12% 7.88% 7.7%
Cost Of Revenue $618.3M $658.3M $561.4M
YoY Change -6.08% 7.61% 8.26%
Gross Profit $265.2M $382.6M $324.9M
YoY Change -30.68% 8.35% 6.73%
Gross Profit Margin 30.02% 36.75% 36.66%
Selling, General & Admin $223.7M $253.1M $230.7M
YoY Change -11.59% 8.15% 9.75%
% of Gross Profit 84.36% 66.14% 71.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $39.90M $45.40M $45.35M
YoY Change -12.11% 5.09% 6.78%
% of Gross Profit 15.05% 11.87% 13.96%
Operating Expenses $223.7M $253.1M $230.7M
YoY Change -11.59% 8.15% 9.75%
Operating Profit -$12.24M $81.92M $47.85M
YoY Change -114.94% 7.24% -5.64%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.600M $3.990M $4.182M
YoY Change -59.9% 363.95% 733.07%
Pretax Income -$19.23M $85.91M $52.03M
YoY Change -122.38% 11.21% 1.6%
Income Tax -$5.478M $20.93M $11.28M
% Of Pretax Income 24.36% 21.67%
Net Earnings -$13.75M $64.98M $40.75M
YoY Change -121.16% 7.7% 2.06%
Net Earnings / Revenue -1.56% 6.24% 4.6%
Basic Earnings Per Share $0.38 $0.24
Diluted Earnings Per Share -$82.98K $0.38 $0.23
COMMON SHARES
Basic Shares Outstanding 166.3M 170.8M 172.6M
Diluted Shares Outstanding 166.3M 171.8M 174.1M

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $898.8M $317.2M $349.7M
YoY Change 183.35% -12.69% 12.92%
Cash & Equivalents $898.8M $267.2M $304.7M
Short-Term Investments $494.0M $172.9M $257.8M
Other Short-Term Assets $155.1M $69.50M $70.90M
YoY Change 123.17% -25.67% -19.25%
Inventory $421.2M $534.8M $456.2M
Prepaid Expenses
Receivables $107.2M $98.60M $73.80M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.582B $1.020B $950.6M
YoY Change 55.13% 2.31% 8.69%
LONG-TERM ASSETS
Property, Plant & Equipment $659.4M $754.0M $744.7M
YoY Change -12.56% 2.96% 1.71%
Goodwill $13.11M $14.88M $14.82M
YoY Change -11.84% -0.34% -0.94%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $63.30M $49.43M $37.68M
YoY Change 28.07% -6.34% -40.38%
Total Long-Term Assets $2.046B $2.339B $2.305B
YoY Change -12.55% 174.0% 169.15%
TOTAL ASSETS
Total Short-Term Assets $1.582B $1.020B $950.6M
Total Long-Term Assets $2.046B $2.339B $2.305B
Total Assets $3.628B $3.359B $3.255B
YoY Change 8.0% 81.5% 88.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $295.3M $317.0M $231.8M
YoY Change -6.84% 19.96% 11.53%
Accrued Expenses $458.2M $368.6M $338.3M
YoY Change 24.31% 116.19% 123.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $840.4M $763.6M $649.8M
YoY Change 10.05% 50.32% 49.45%
LONG-TERM LIABILITIES
Long-Term Debt $517.0M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $19.60M $28.30M $35.14M
YoY Change -30.73% -65.55% -60.38%
Total Long-Term Liabilities $1.790B $1.367B $1.364B
YoY Change 30.93% 1563.91% 1437.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $840.4M $763.6M $649.8M
Total Long-Term Liabilities $1.790B $1.367B $1.364B
Total Liabilities $2.630B $2.131B $2.014B
YoY Change 23.44% 261.01% 284.64%
SHAREHOLDERS EQUITY
Retained Earnings $1.808B $2.070B $2.029B
YoY Change -12.68% 6.62% 6.53%
Common Stock $649.8M $570.9M $572.9M
YoY Change 13.81% 1.43% 0.95%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.412B $1.376B $1.324B
YoY Change 2.6% 13.59% 7.73%
Treasury Stock Shares $83.48M $80.60M $77.70M
Shareholders Equity $997.9M $1.229B $1.242B
YoY Change
Total Liabilities & Shareholders Equity $3.628B $3.359B $3.255B
YoY Change 8.0% 81.5% 88.07%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$13.75M $64.98M $40.75M
YoY Change -121.16% 7.7% 2.06%
Depreciation, Depletion And Amortization $39.90M $45.40M $45.35M
YoY Change -12.11% 5.09% 6.78%
Cash From Operating Activities $173.5M $109.9M $7.719M
YoY Change 57.87% -11.66% -72.42%
INVESTING ACTIVITIES
Capital Expenditures -$27.70M -$56.20M $36.57M
YoY Change -50.71% 2.93% -22.02%
Acquisitions
YoY Change
Other Investing Activities $30.00M -$5.000M $203.0K
YoY Change -700.0% -75.0% -35.35%
Cash From Investing Activities $2.300M -$61.30M $10.36M
YoY Change -103.75% -17.83% -115.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.00M
YoY Change -55.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -134.4M -86.20M -46.64M
YoY Change 55.92% 419.28% -44.66%
NET CHANGE
Cash From Operating Activities 173.5M 109.9M 7.719M
Cash From Investing Activities 2.300M -61.30M 10.36M
Cash From Financing Activities -134.4M -86.20M -46.64M
Net Change In Cash 41.40M -37.60M -28.66M
YoY Change -210.11% -213.25% -76.8%
FREE CASH FLOW
Cash From Operating Activities $173.5M $109.9M $7.719M
Capital Expenditures -$27.70M -$56.20M $36.57M
Free Cash Flow $201.2M $166.1M -$28.86M
YoY Change 21.13% -7.21% 52.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
659351000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
30224000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
348921000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1271491000
CY2020Q3 us-gaap Inventory Net
InventoryNet
421196000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
107243000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19604000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
51281000
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
12783000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
516953000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1253105000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66131000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
840414000
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1789662000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1927169000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.003
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.006
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.431
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.487
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
249566000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
166090000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
2496000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
647284000
CY2020Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
22837000
CY2020Q3 aeo Unredeemed Gift Cards And Gift Certificates Current
UnredeemedGiftCardsAndGiftCertificatesCurrent
43165000
aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
4272000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
89661000
us-gaap Operating Income Loss
OperatingIncomeLoss
129768000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6993000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3990000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19230000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
85912000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5478000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20931000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13752000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
64981000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166315000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170756000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1807687000
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
83476000
CY2020Q3 us-gaap Gross Profit
GrossProfit
265199000
us-gaap Gross Profit
GrossProfit
293505000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
223711000
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1411576000
CY2020Q3 aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
14611000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47991000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
997900000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3627976000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
883510000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
658308000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1141697000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1219677000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1375
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1798000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39114000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12237000
us-gaap Operating Income Loss
OperatingIncomeLoss
-370478000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8172000
CY2019Q3 us-gaap Gross Profit
GrossProfit
382571000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
81922000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
411908000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
483791000
CY2019Q3 aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
2728000
aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
170231000
us-gaap Gross Profit
GrossProfit
707492000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
253051000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
137940000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32206000
us-gaap Net Income Loss
NetIncomeLoss
105734000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44870000
us-gaap Net Income Loss
NetIncomeLoss
105734000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
81844000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10122000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-380600000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-109685000
us-gaap Net Income Loss
NetIncomeLoss
-270915000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166461000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166461000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14823000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1228577000
CY2019Q3 aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
4423000
CY2019Q3 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
1569000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
64981000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
996983000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11436000
CY2020Q3 aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
3785000
CY2020Q3 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-82000
us-gaap Profit Loss
ProfitLoss
-270915000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166315000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171781000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13752000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
64981000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14823000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1241751000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9207000
CY2019Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
60000000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1276000
CY2019Q3 us-gaap Dividends Common Stock
DividendsCommonStock
23232000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13752000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7059000
CY2020Q3 aeo Cash Dividends Declared And Dividend Equivalents
CashDividendsDeclaredAndDividendEquivalents
41000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
997900000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1287555000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14166000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
80000000
aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
7921000
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
2141000
us-gaap Net Income Loss
NetIncomeLoss
105734000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1798000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.275
us-gaap Dividends Common Stock
DividendsCommonStock
46865000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1247853000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15354000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20000000
aeo Share Repurchases Related To Employee Stock Based Compensation Awards Value
ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
5215000
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
68330000
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-379000
us-gaap Net Income Loss
NetIncomeLoss
-270915000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14823000
us-gaap Dividends Common Stock
DividendsCommonStock
22305000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
997900000
us-gaap Profit Loss
ProfitLoss
105734000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
83305000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
90787000
us-gaap Share Based Compensation
ShareBasedCompensation
15654000
us-gaap Share Based Compensation
ShareBasedCompensation
14298000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5437000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11823000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
153617000
us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
-22119000
us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
110768000
aeo Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-142564000
aeo Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-120241000
aeo Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-70831000
aeo Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-132279000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
94433000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
898787000
CY2020Q3 us-gaap Number Of Stores
NumberOfStores
1000
CY2020Q3 aeo Number Of International Store Locations
NumberOfInternationalStoreLocations
200
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
27368000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8591000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
76326000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
22797000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-27436000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-43450000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3761000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36419000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
117597000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61402000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91793000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
14956000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
50000000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
69956000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
92135000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
372000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1201000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6774000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50859000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
80000000
aeo Payments To Repurchase Common Stock From Employees
PaymentsToRepurchaseCommonStockFromEmployees
5215000
aeo Payments To Repurchase Common Stock From Employees
PaymentsToRepurchaseCommonStockFromEmployees
7921000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
736108000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
130000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2119000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
46865000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-682000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-108000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
580211000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-132775000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-161000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-127000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
536857000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66164000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
333330000
CY2020Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
84100000
us-gaap Fiscal Period
FiscalPeriod
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fiscal Year</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our fiscal year is a 52- or 53-week year that ends on the Saturday nearest to January 31. As used herein, “Fiscal 2020” refers to the 52-week period that will end on January 30, 2021.  “Fiscal 2019” refers to the 52-week period ended February 1, 2020.  “Fiscal 2018” refers to the 52-week period ended February 2, 2019. </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, our management reviews its estimates based on currently available information. Changes in facts and circumstances may result in revised estimates.</p>
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7100000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14800000
CY2019Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
51500000
CY2019Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q3 aeo Percentage Of Net Sales
PercentageOfNetSales
1
CY2019Q3 aeo Percentage Of Net Sales
PercentageOfNetSales
1
aeo Percentage Of Net Sales
PercentageOfNetSales
1
aeo Percentage Of Net Sales
PercentageOfNetSales
1
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
883510000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1040879000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1435202000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1927169000
CY2020Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
aeo Property Plant And Equipment Weighted Average Useful Life
PropertyPlantAndEquipmentWeightedAverageUsefulLife
P7Y6M
CY2020Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2019Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q3 aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
1600000
CY2019Q3 aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
1800000
aeo Revenue Related To Gift Card Breakage
RevenueRelatedToGiftCardBreakage
3300000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
898787000
CY2020Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
361930000
CY2019Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
267166000
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
55000000
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
50000000
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
898787000
CY2020Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
416930000
CY2019Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
317166000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166315000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170756000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166461000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1025000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1410000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166315000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171781000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166461000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173701000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8235000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
768000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4670000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
434000
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
8.75
CY2020Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
2400000
CY2020Q3 us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.0195
us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.0215
CY2020Q3 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
1300000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
516953000
CY2020Q3 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
68330000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
11600000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7000000.0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y4M24D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
9100000
us-gaap Share Based Compensation
ShareBasedCompensation
15700000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
9500000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
9300000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7000000.0
us-gaap Share Based Compensation
ShareBasedCompensation
14300000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
10900000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2584000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.18
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1705000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
26000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
20.79
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4263000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1286000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3195000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
15.62
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1123000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1807000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.08
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2100000
aeo Employee Service Share Based Compensation Tax Benefit Expense Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitExpenseRealizedFromExerciseOfStockOptions
100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.024
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.382
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
153600000
CY2020Q1 aeo Cares Act Of2020 Net Operating Loss Carryback Period
CARESActOf2020NetOperatingLossCarrybackPeriod
P5Y
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.285
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2020Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
600000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
153617000
CY2020Q3 aeo Incremental Corona Virus Disease Two Thousand And Nineteen Related Expenses
IncrementalCoronaVirusDiseaseTwoThousandAndNineteenRelatedExpenses
13885000
aeo Incremental Corona Virus Disease Two Thousand And Nineteen Related Expenses
IncrementalCoronaVirusDiseaseTwoThousandAndNineteenRelatedExpenses
13885000
CY2020Q3 us-gaap Restructuring Costs
RestructuringCosts
726000
CY2019Q3 us-gaap Restructuring Costs
RestructuringCosts
2728000
us-gaap Restructuring Costs
RestructuringCosts
2729000
us-gaap Restructuring Costs
RestructuringCosts
4272000
CY2020Q3 aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
14611000
CY2019Q3 aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
2728000
aeo Impairment Restructuring And Corona Virus Disease Nineteen Related Charges
ImpairmentRestructuringAndCoronaVirusDiseaseNineteenRelatedCharges
170231000
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
4187000
aeo Restructuring Charge Cash Charges
RestructuringChargeCashCharges
16613000
aeo Payments For Restructuring And Restructuring Reserve Accrual Adjustment
PaymentsForRestructuringAndRestructuringReserveAccrualAdjustment
16622000
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
4178000

Files In Submission

Name View Source Status
0001564590-20-042969-index-headers.html Edgar Link pending
0001564590-20-042969-index.html Edgar Link pending
0001564590-20-042969.txt Edgar Link pending
0001564590-20-042969-xbrl.zip Edgar Link pending
aeo-10q_20200801.htm Edgar Link pending
aeo-10q_20200801_htm.xml Edgar Link completed
aeo-20200801.xsd Edgar Link pending
aeo-20200801_cal.xml Edgar Link unprocessable
aeo-20200801_def.xml Edgar Link unprocessable
aeo-20200801_lab.xml Edgar Link unprocessable
aeo-20200801_pre.xml Edgar Link unprocessable
aeo-ex311_9.htm Edgar Link pending
aeo-ex312_7.htm Edgar Link pending
aeo-ex321_6.htm Edgar Link pending
aeo-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending